Cagliflozin and Engelezin are the same class of drugs, belonging to the same sodium-glucose cotransporter protein 2 inhibitors, the efficacy of the drug is similar, did not say that which efficacy is better, diabetic patients should be guided by a doctor to choose the right drug for their own condition. These drugs can be used alone or in combination with other oral hypoglycemic drugs and insulin to treat type 2 diabetes. The most common adverse reactions to this product are fungal infections of the female genitalia, urinary tract infections, increased urination, etc. It is contraindicated in patients who are allergic to this product, have severe renal impairment or are on dialysis. When using Cagliflozin or Engegliflozin, it is recommended that patients should also carry out dietary control and appropriate exercise to adjust their blood sugar. It is recommended that patients should use glucose-lowering drugs under the guidance of a doctor, do not self-medicate, which may aggravate the condition or produce adverse reactions, and monitor blood glucose regularly to adjust the medication.